| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-1647117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:DEPTOR-IN-1 CAS:2615911-12-9 Purity:98% Package:10mg;25mg;50mg;100mg Remarks:BD01457097
|
4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- manufacturers
- DEPTOR-IN-1
-
- $81.00
-
2026-07-04
- CAS:2615911-12-9
- Purity: 97.84%
- Supply Ability: 10g
|
| | 4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- Basic information |
| Product Name: | 4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- | | Synonyms: | 4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy-;DEPTOR-IN-1;DEPTORIN1,inhibit,DEPTOR IN 1,Inhibitor | | CAS: | 2615911-12-9 | | MF: | C24H16Cl2FNO4 | | MW: | 472.29 | | EINECS: | | | Product Categories: | | | Mol File: | 2615911-12-9.mol | ![4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- Structure](CAS/20210305/GIF/2615911-12-9.gif) |
| | 4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- Chemical Properties |
| Boiling point | 617.1±55.0 °C(Predicted) | | density | 1.525±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | form | Solid | | pka | 7.96±0.20(Predicted) | | color | Light yellow to yellow |
| | 4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- Usage And Synthesis |
| Uses | DEPTOR-IN-1 is a novel putative DEPTOR inhibitor with a Kd value of 9.3 μM. | | Biological Activity | DEPTOR-IN-1 is a novel putative DEPTOR inhibitor with a Kd value of 9.3 μM. | | References | [1]. Hou Y, et al. Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment. J Med Chem. 2021 Oct 28;64(20):14942-14954. |
| | 4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-9,10-dihydro-3-hydroxy- Preparation Products And Raw materials |
|